Depakote (Valproate) Linked To Birth Defects And Fetal Death

In a recent study, one in five women who took the epilepsy drug Valproate during pregnancy resulted in birth defects or fetal death. The drug, sold by Abbott Laboratories, Inc., under the brand name Depakote, was found to be substantially riskier than any of the other three main epilepsy available on the market. Some of the defects commonly found to have occurred include: malformed hearts and genitals, cleft palate, and artery deformities.  If you or a loved one have taken Valprote during a pregnancy which resulted in birth defects or fetal death contact a personal injury attorney immediately to protect your rights.